SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-21-001197
Filing Date
2021-08-27
Accepted
2021-08-27 17:23:55
Documents
8
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K medicure6k.htm 6-K 13341
2 Q2 FINANCIAL STATEMENTS ex991.htm EX-99.1 314942
3 Q2 MD&A ex992.htm EX-99.2 314465
4 CEO CERTIFICATION ex993.htm EX-99.3 5499
5 CFO CERTIFICATION ex994.htm EX-99.4 5485
6 GRAPHIC ex992_sig.jpg GRAPHIC 5171
7 GRAPHIC logo.jpg GRAPHIC 13399
8 GRAPHIC logo_header.jpg GRAPHIC 8148
  Complete submission text file 0001279569-21-001197.txt   691920
Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31995 | Film No.: 211220142
SIC: 2834 Pharmaceutical Preparations